The European Medicines Agency’s (EMA) human medicines committee (CHMP) has started a rolling review of CVnCoV, a COVID 19 vaccine being developed by German mRNA
RAND study finds US Rx drug prices 2.56 times higher than in other countries
AstraZeneca’s biologic combo AZD7442 for COVID-19 moving ahead
India pushes for vaccine diplomacy in South Asia